Ensuring the conformity of polymeric products for pharmaceutical use presents a dual challenge. These materials exhibit complex, statistical structures that require tight control over multiple parameters to ensure safety and efficacy. At the same time, the range of analytical technologies suitable for routine polymer analysis remains limited.
Among the few techniques capable of meeting these demands, Nuclear Magnetic Resonance (NMR) stands out, offering direct, absolute measurements of key structural features. This whitepaper illustrates NMR’s capabilities in polymer analysis through the compendial testing of Linear Alcohol Ethoxylates (AEs), a significant class of non-ionic surfactants.
It highlights the Bruker Fourier 80 benchtop NMR spectrometer—a compact, cryogen-free system tailored for Quality Control (QC) laboratories. With built-in regulatory compliance features, the Fourier 80 delivers simple, cost-effective access to NMR technology. It supports both qualitative and quantitative testing of organic compounds and offers a versatile toolkit for routine and investigational polymer analysis.
Download the full whitepaper here.
About Bruker BioSpin - NMR, EPR and Imaging - Pharma
Welcome to Bruker BioSpin and the world's most comprehensive range of NMR and EPR spectroscopy and preclinical imaging research tools. The Bruker BioSpin Group of companies develop, manufacture and supply technology to research establishments, commercial enterprises and multi-national corporations across countless industries and fields of expertise.
Bruker BioSpin is continuing to revolutionize the design, manufacture and distribution of life science, preclinical, process control and analytical research tools based on magnetic resonance and multimodal imaging technologies. Bruker BioSpin is the worldwide technology and market leader in magnetic resonance technologies (NMR, EPR) and offers the largest portfolio of imaging modalities for preclinical and industrial research under a single brand.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.